☆ 4.7 Article

Incidence, Outcomes and Risk Factors of Recurrent Ventilator Associated Pneumonia in COVID-19 Patients: A Retrospective Multicenter Study

JOURNAL OF CLINICAL MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Critical Care Medicine

Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients

Jacopo Fumagalli et al.

Summary: This review summarized the available evidence regarding the incidence, risk factors, and clinical characteristics of ventilator-associated pneumonia (VAP) in patients undergoing mechanical ventilation due to acute respiratory distress syndrome secondary to SARS-CoV-2 infection (C-ARDS). The majority of VAP cases were caused by Gram-negative bacteria, with occasional cases attributed to herpes virus reactivations and pulmonary aspergillosis. Potential factors driving high VAP incidence rates included immunoparalysis, prolonged ventilation, exposure to immunosuppressants, understaffing, lapses in prevention processes, and overdiagnosis.

CURRENT OPINION IN CRITICAL CARE (2022)

添加到收藏夹

Article Medicine, General & Internal

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Shruti Gupta et al.

Summary: A multicenter cohort study found that early treatment with tocilizumab may reduce mortality among critically ill patients with COVID-19. Further research from randomized clinical trials is needed to confirm these findings.

JAMA INTERNAL MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study

Anahita Rouze et al.

Summary: The incidence of ventilator-associated lower respiratory tract infections (VA-LRTI) is significantly higher in patients with SARS-CoV-2 infection compared to those with influenza pneumonia or no viral infection. Gram-negative bacilli, mainly Pseudomonas aeruginosa, Enterobacter spp., and Klebsiella spp., were responsible for a large proportion of VA-LRTI episodes.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Article Immunology

Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis

Asma Boumaza et al.

Summary: The study found that monocytes and macrophages from COVID-19 patients can be infected by SARS-CoV-2, leading to secretion of immunoregulatory cytokines and induction of a specific transcriptional program in macrophages. Single-cell analysis in COVID-19 patients revealed lower monocyte counts affecting all subsets, decreased expression of HLA-DR, and increased expression of CD163, regardless of disease severity.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Critical Care Medicine

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

Laura Evans et al.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Letter Immunology

Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study

Gilles Kaplanski et al.

AUTOIMMUNITY REVIEWS (2021)

添加到收藏夹

Article Critical Care Medicine

Increased susceptibility to intensive care unit-acquired pneumonia in severe COVID-19 patients: a multicentre retrospective cohort study

Jean-Francois Llitjos et al.

Summary: The study showed that COVID-19 patients have a higher risk of developing ICU-acquired pneumonia compared to patients with bacterial or non-SARS-CoV-2 viral pneumonia. The risk of ICU-acquired pneumonia remained independently associated with COVID-19 in mechanically ventilated patients, suggesting a potential unique pathogenesis of pneumonia in COVID-19 patients. Additional research is needed to investigate the underlying mechanisms leading to this increased risk.

ANNALS OF INTENSIVE CARE (2021)

添加到收藏夹

Article Medicine, General & Internal

Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study

Daniele Roberto Giacobbe et al.

Summary: This study aimed to assess the incidence rate of ventilator-associated pneumonia in COVID-19 patients in intensive care units, finding that VAP is frequent and associated with a high fatality rate, likely due to the cumulative impact of the underlying viral disease and superimposed bacterial infections.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Effects of dexamethasone on immune dysfunction and ventilator-associated pneumonia in COVID-19 acute respiratory distress syndrome: an observational study

Martin Cour et al.

Summary: The use of dexamethasone in treating COVID-19 patients may exacerbate immune dysfunction and lead to early onset of ventilator-associated pneumonia.

JOURNAL OF INTENSIVE CARE (2021)

添加到收藏夹

Article Critical Care Medicine

Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia

Chiagozie O. Pickens et al.

Summary: In patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation, bacterial superinfection occurs in 25% of patients at the time of intubation. Empirical antibiotic management based on guidelines leads to antibiotic overuse, while BAL-based management reduces antibiotic use significantly. VAP develops in 44% of patients and accurate identification relies on microbiologic analysis of BAL fluid.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study

Ines Gragueb-Chatti et al.

Summary: In COVID-19 patients requiring invasive mechanical ventilation, dexamethasone treatment was not associated with increased incidence of ventilator-associated pneumonia or bloodstream infections. Dexamethasone may not explain the high rates of VAP and BSI observed in critically ill COVID-19 patients.

ANNALS OF INTENSIVE CARE (2021)

添加到收藏夹

Article Critical Care Medicine

Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort

Saad Nseir et al.

Summary: This study found that VAP was significantly associated with increased 28-day mortality in SARS-CoV-2 patients, but SARS-CoV-2 pneumonia did not significantly modify the relationship between VAP and 28-day mortality compared to influenza pneumonia or no viral infection.

CRITICAL CARE (2021)

添加到收藏夹

Article Critical Care Medicine

Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region

Gauthier Blonz et al.

Summary: The study analyzed data from 188 patients hospitalized for severe COVID-19 in ICUs, showing a high incidence of VAP with a significant proportion of enterobacteria, and higher risk in male patients. Complications such as abscess and empyema were not exceptional in VAP cases.

CRITICAL CARE (2021)

添加到收藏夹

Article Critical Care Medicine

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Matthieu Schmidt et al.

Summary: Among more than 4000 critically ill patients with COVID-19 admitted to our ICUs, 90-day mortality was 31% and decreased from 42 to 25% over the study period. Mortality was higher in older, diabetic, obese and severe ARDS patients.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

Alexis Tabah et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Editorial Material Critical Care Medicine

Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists

Lila Bouadma et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Review Critical Care Medicine

Ventilator-associated pneumonia in adults: a narrative review

Laurent Papazian et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Editorial Material Critical Care Medicine

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation

Daniel E. Leisman et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Critical Care Medicine

Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS

Carlos Ferrando et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial

Bruno M. Tomazini et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Biology

Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia

Michaela Gregorova et al.

ELIFE (2020)

添加到收藏夹

Article Critical Care Medicine

Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study

Charles-Edouard Luyt et al.

ANNALS OF INTENSIVE CARE (2020)

添加到收藏夹

Article Critical Care Medicine

Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease

Keyvan Razazi et al.

CRITICAL CARE (2020)

添加到收藏夹

Article Immunology

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

Andre C. Kalil et al.

CLINICAL INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Respiratory System

Optimising the duration of antibiotic therapy for ventilator-associated pneumonia

J. Chastre et al.

EUROPEAN RESPIRATORY REVIEW (2007)

添加到收藏夹

Article Critical Care Medicine

Methylprednisolone infusion in early severe ARDS - Results of a randomized controlled trial

G. Umberto Meduri et al.

CHEST (2007)

添加到收藏夹

Review Critical Care Medicine

Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia

[Anonymous]

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

添加到收藏夹

Article Medicine, General & Internal

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial

J Chastre et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.